News from NYU Langone Health
21 Health Systems With Credit Rating Upgrades. (Becker's Hospital Review)
Becker’s Hospital Review (11/19) NYU Langone Health has had its credit rating upgraded from “A2” to “A1” by Moody’s Investor Services in 2024, which is attributed to the health system’s anticipated ongoing strong and consistent operating performance and revenue growth compared to its peers, “driven by its strong market position and highly effective and disciplined leadership.”
Using AI To Match Patients To Clinical Trials. (Politico)
Politico (11/19) A new artificial intelligence algorithm created by NIH researchers, released on Monday, may facilitate enrollment of underrepresented populations in advanced research, with Arthur Caplan, the Drs. William F. and Virginia Connolly Mitty Professor of Bioethics, Division of Medical Ethics, Department of Population Health, saying, it is important “to ensure that patients consent to their data being used” once the tool is deployed in real settings.
ACR: Colchicine No Benefit For Painful Knee Osteoarthritis. (HealthDay)
HealthDay (11/19) A recent study revealed that colchicine does not enhance knee pain, function, or synovial effusion size in knee osteoarthritis, with Jonathan Samuels, MD, associate professor, Department of Medicine, Division of Rheumatology and colleagues, saying, “Whether longer treatment with colchicine, higher doses, or a larger cohort would improve pain and function or modify radiographic progression remains to be determined.”
Also reporting is McKnight’s Senior Living (11/19).
Study Compares Cutaneous Toxicities Of Two MEK Inhibitors In Children. (Medscape)
Paywalled* Medscape (11/20)* A retrospective study conducted at NYU Langone Health analyzed the cutaneous adverse events associated with MEK inhibitors in pediatric patients, revealing that binimetinib caused more severe reactions than selumetinib, with severe events occurring in 90.9% of binimetinib patients compared to 46.2% of those on selumetinib; the study, led by Carli D. Needle, medical student, the Ronald O. Perelman Department of Dermatology, also found that older children experienced higher rates of acneiform eruptions and seborrheic dermatitis, while younger children had more xerosis, and the severity of skin events was not linked to tumor response.
Earlier Diabetes Diagnosis Linked To Dementia Risk. (Mirage News (AUS))
Mirage News (AUS) (11/19) A study conducted by researchers at the NYU Rory Meyers College of Nursing indicates that individuals diagnosed with type 2 diabetes at a younger age face a higher risk of developing dementia compared to those diagnosed later, with study authors including Zheng Zhu of NYU Meyers, Huabin Luo of East Carolina University, and Mark D. Schwartz, MD, professor, Departments of Population Health, and Medicine, Division of General Internal Medicine and Clinical Innovation.
New Study Reveals Expanded Eligibility For Ozempic: What To Know. (TODAY)
TODAY (11/19) Natalie E. Azar, MD, clinical associate professor, Department of Medicine, Division of Rheumatology, explained that nearly 140 million people are eligible for weight loss medication, noting that “about 129 million people would be eligible to manage their weight, about 35 million to manage diabetes, and about 8.9 million people to manage heart disease.”
Also reporting is NBC News Now-2 (11/19).
Fact Vs. Myth: What To Know About Healthy Eating. (TODAY)
TODAY (11/19) In discussing healthy eating myths, Natalie E. Azar, MD, clinical associate professor, Department of Medicine, Division of Rheumatology, said, “Multi-grain is very deceptive,” noting that whole grains are the healthier grain choice and can lower the risk for heart disease, stroke, diabetes, and colorectal cancer.
